Connect with us

Research

Older women may become more sensitive to pain than men – study

Published

on

New research suggests that gender differences in pain perception may become more disparate with age.

The study found that the brain system which enables us to inhibit our own pain changes with age, and that gender-based differences in those changes, may lead older females to be more sensitive to moderate pain than males as older adults.

Researchers used fMRI scans to examine brain responses in men and women who had rated the intensity and unpleasantness of pain during exposure to increasing levels of heat.

The results, published recently in The Journal of Pain, suggested that established gender differences in pain perception could likely be traced at least in part to this brain network, and offered new evidence that those gender differences may become more disparate with age.

“The most novel part of this study is looking at gender by age,” said lead study author Michelle Failla, assistant professor in the College of Nursing at The Ohio State University.

“Most of the work characterising which regions in the brain respond to pain have been done in people aged 18 to 40. We want to understand what’s happening between the ages of 30 and 90-years-old because that’s when people are beginning to experience chronic pain.”

Plenty of previous research has shown that females are more sensitive to pain than males, but the brain regions and functions behind the gender differences in pain perception have mostly remained a mystery. And in later adulthood, when risk for chronic pain is higher and our tolerance for pain drops, even less about the brain’s role in pain perception is known.

In this study, the researchers specified that they holistically examined gender-based differences that may relate not just to biological sex, but also to social factors that influence how people respond to pain.

The imaging component of the study zeroed in on the descending pain modulatory system (DPMS), a hub of brain regions that communicate with each other to engage signal transmission – including activation of opioid receptors – that enables us to reduce our own pain.

The study sample included 27 females and 32 males between ages 30 and 86 who were asked to report when applied heat reached levels of just-noticeable, weak and moderate pain and to rate how unpleasant each level felt. Researchers used the fMRI imaging to observe DPMS activity that corresponded with each participant’s individual pain response.

“There are different brain regions involved in those distinctions between perception of pain intensity and unpleasantness, so we thought it was important to look at both and see how those brain regions are recruited during pain,” said Failla, also an investigator in the Center for Healthy Aging, Self-Management and Complex Care in Ohio State’s College of Nursing.

Results showed that a few regions within the brain’s pain modulatory system did indicate a gender-by-age difference: At the moderate pain level, men showed an increased DPMS response with older age, while as women aged, the DPMS response decreased. A decreased response in the brain is presumed to translate into a lower ability to harness our own physiological functions to reduce our pain.

Presumed is a key word: While the DPMS is believed to have a significant role in pain sensitivity and tolerance, researchers are still working toward describing exactly how it works and how an intact versus dysfunctional system shows up in scans.

“We don’t know exactly what is an optimum DPMS response,” Failla said. “Are we seeing it activated to catch up with your pain, or is it already working, meaning the pain could have been worse?”

The researchers are continuing this work, which includes investigating brain activity in people who may have a difficult time articulating the pain that they’re feeling – such as people with dementia or autism.

The more scientists can learn about the brain’s role in pain perception, the better the chances are for more effective pain management, Failla said.

“Pain is such an individual experience. In science we’re moving toward individual factors that can influence pain specifically and what makes it different for each person,” she said. “This could then identify a mechanism we can target, or even just give us a better understanding that there are different levels of innate abilities to modulate pain.”

This study was conducted at Vanderbilt University Medical Center and was supported by a National Institute on Aging grant awarded to co-authors Todd Monroe of Ohio State and Ronald Cowan of the University of Tennessee Health Science Center.

Other co-authors include Paul Beach of Emory University, Sebastian Atalla of the University of North Carolina, and Mary Dietrich and Stephen Bruehl of Vanderbilt University.

News

Finding could help identify diabetes patients at risk of vascular damage

Published

on

The longer someone has type 2 diabetes, the higher their cardiovascular disease risk, and changes in red blood cells may help explain it, new research suggests.

The study found red blood cells from patients with long-term diabetes harmed blood vessel function, while no such effect was seen in those newly diagnosed.

After seven years of follow-up, the blood cells of people initially diagnosed had developed the same harmful properties.

Zhichao Zhou, associate professor at Karolinska Institutet and lead author, said: “What really stands out in our study is that it is not only the presence of type 2 diabetes that matters, but how long you have had the disease.

“It is only after several years that red blood cells develop a harmful effect on blood vessels.”

Researchers at Karolinska Institutet in Sweden studied animals and patients with type 2 diabetes.

They identified microRNA-210, a small RNA that helps regulate gene activity, as a possible early biomarker of cardiovascular risk.

When its levels were restored in red blood cells, blood vessel function improved.

Eftychia Kontidou, doctoral student and first author, said: “If we can identify which patients are at greatest risk before vascular damage has already occurred, we can also become better at preventing complications.”

The researchers are now investigating whether the biomarker can be used in larger population studies.

Continue Reading

News

Routine vaccines may protect against dementia, research finds

Published

on

Routine vaccines for adults may reduce dementia risk, a review of more than 100 million people suggests.

The research found both flu and shingles vaccines were associated with a lower risk in adults aged 50 and over.

The shingles (herpes zoster) jab was linked to a 24 per cent lower risk of any dementia and a 47 per cent lower risk of Alzheimer’s disease.

A joint Italian-Canadian neuroscience review points to a pattern that public health experts say is hard to ignore, suggesting vaccines against common infections may offer long-term protection against the UK’s leading cause of death.

With an ageing population, about two million people are projected to be living with dementia in the UK by 2050.

Prof Sir Andrew Pollard is director of the Oxford Vaccine Group and former chair of the Joint Committee on Vaccination and Immunisation.

He said: “Vaccines for pneumonia, shingles, and influenza in older adults have been shown to reduce the risk of serious infections and hospitalisation caused by these diseases.

“But studies in the past few years have raised the intriguing possibility that vaccination could also provide a welcome reduction in the risk of dementia, a disease which places a huge burden on society and the NHS.”

A separate large-scale randomised trial in Wales compared shingles vaccines Zostavax and Shingrix to address the “healthy user effect”, where people who get vaccinated tend to be more health-conscious. As both groups were vaccinated, this helped control for that bias.

The results showed those receiving the newer Shingrix vaccine had a substantially lower risk of developing dementia over subsequent years.

Dr Maxime Taquet, clinical lecturer in psychiatry at Oxford, who led that study, said: “The size and nature of this study makes these findings convincing, and should motivate further research.”

Continue Reading

News

Weaker body clock linked to increased dementia risk

Published

on

Weaker, fragmented body clocks are linked to higher dementia risk, new research suggests.

The study also found that people whose activity levels peaked later in the day, rather than earlier, faced a higher risk.

Circadian rhythm is the body’s internal clock, regulating the 24-hour sleep-wake cycle and other processes including hormones, digestion and body temperature.

With a strong rhythm, the body clock aligns well with the 24-hour day, sending clear signals for body functions.

Researchers at UT Southwestern Medical Center in Texas studied 2,183 people with an average age of 79 who did not have dementia.

Participants wore small heart monitors for an average of 12 days to measure rest and activity patterns.

Over an average follow-up of three years, 176 people developed dementia. Those with weaker rhythms had nearly 2.5 times the risk of dementia compared to those with the strongest rhythms.

People whose activity peaked at 2.15pm or later had a 45 per cent increased risk compared to those peaking earlier in the afternoon.

Wendy Wang, the study author, said: “Changes in circadian rhythms happen with ageing, and evidence suggests that circadian rhythm disturbances may be a risk factor for neurodegenerative diseases like dementia.

“Disruptions in circadian rhythms may alter body processes like inflammation, and may interfere with sleep, possibly increasing amyloid plaques linked to dementia, or reducing amyloid clearance from the brain.

“Future studies should examine the potential role of circadian rhythm interventions, such as light therapy or lifestyle changes, to determine if they may help lower a person’s risk of dementia.”

Continue Reading

Trending

Agetech World